News About: Pharm. Industry
Over 600 BW level of outpatient prescriptions issued in June.
A monthly 600 billion won of the prescription issuance for outpatients was repeated again in June this year following the end of last year, showing ever rising trend of the prescription drug markets as well as a remar...
Lip care market heats up
This year's lip care market is expected to become fierce between foreign and domestic makers, stepping up more aggressive marketing campaigns towards pharmacies with a variety of massive incentives and gift offerings....
Hwail targets aggressive expansion
Hwail Pharm, a local pharmaceutical bulk manufacturer, has pledged an aggressive expansion strategy in functional food market.
Hwail posted net income of 4.5 billion won in 2006 with its gross sales of 54.9 billion...
Korea top brand of liver protective drug, Ursa, raised its price.
Taking effect from the coming August, the unit price of Ursa PTP packs will be increased by 10%. Ursa has been known as one of the top brand drugs for the protection of liver.
According to the pharmaceutical dist...
Kyungdong's Reductil modified new drug to be soon approved.
Kyungdong pharmaceutical company announced on July 13 that a modified drug of sibutramine (Reductil), an anti-obesity drug, called Silumin capsule would be approved by the KFDA shortly around the coming Oct.
Kyungd...
Novartis's Zelmac to be released soon
Zelmac, a drug used to treat irritable bowel syndrome, will be on the market shortly, according to Novartis Korea.
Sales of the drug have been temporarily halted from April owing its link to an increased risk of he...
Prices of three original drugs price to fall by 20 percent
The Ministry of Health and Welfare said on July 12 that health insurance price of three items GSK's GSK's Lamictal tablets, Pfizer's Detrusitol (tolterodine tartrate) tablets 1mg/4 mg will be reduced by 20 percent f...
Novartis Korea to resubmit world data for Sebivo.
Novartis Korea was embarrassed at encountering the NHI price approval rejection for Sebivo (telbivudine), a chronic B hepatitis therapy on July 12, and CEO Andrin Oswald of Novartis Korea regretted to say "No chances ...
Pharmacists to return smaller packets of Reductil
Pharmacists will be compensated for small packages of Reductil (sibutramine), an anti-obesity agent as Abbott Korea and Ilsung Pharm agreed to replace the drugs by new versions.
In its reply to the petition raised ...
cGMP consulting business will be hot
cGMP consulting is expected to emerge as a flourishing business as the Food and Drug Administration (KFDA) plans to implement, by phase, the cGMP system until 2010 in a bid to upgrade its GMP level to that of advanced...
